Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Yarrow Bioscience entered into an underwriting agreement to sell 5,769,231 shares of common stock at $26.00 per share. The underwriters fully exercised their option to purchase an additional 865,384 shares, bringing the total expected net proceeds to approximately $161.8 million after expenses.
Value
$172M
Counterparty
Jefferies LLC, TD Securities (USA) LLC and Guggenheim Securities, LLC
Trilogy Metals closed a $17.8 million strategic equity investment from the U.S. Department of War, issuing 8,215,570 units at $2.17 per unit. The U.S. Government becomes an approximately 10% shareholder to advance domestic copper and cobalt supply from the Upper Kobuk Mineral Projects in Alaska.
Allarity Therapeutics announced that its newly formed SPAC, Allarity Acquisition Corp., has filed a Registration Statement for a proposed $100 million IPO ($115 million including overallotment). Allarity's subsidiary will act as the sponsor and is expected to own approximately 25% of the SPAC following the offering.
Harvard Apparatus Regenerative Technology Capital Raise of $2.84M
Harvard Apparatus Regenerative Technology closed a private placement of 2,703,727 shares of common stock at $1.05 per share for total proceeds of approximately $2.84 million. The transaction included a $717,911 debt-for-equity conversion by CEO Jerry (Junli) He, who cancelled outstanding bridge promissory notes in exchange for shares at the same offering price.
XBP Global Holdings entered into securities purchase agreements to raise approximately $6.05 million through a private placement of 2,275,245 shares of common stock. The offering included participation from company insiders, including the CEO, CFO, and affiliates of the Executive Chairman and a Board member, at prices ranging from $2.55 to $2.83 per share. Proceeds are intended for general corporate purposes, and the company has committed to filing a resale registration statement for the shares by September 22, 2026.
Value
$6.05M
Counterparty
Avenue Capital Group, HCI LLC, and other accredited investors
Enbridge Inc. completed a bought deal public offering of 44,735,000 common shares, including the full exercise of an over-allotment option. The offering generated gross proceeds of approximately CDN$3.0 billion. The transaction was conducted through a syndicate of underwriters led by RBC Dominion Securities and CIBC World Markets.
Counterparty
RBC Dominion Securities Inc. and CIBC World Market Inc.
Cabaletta Bio announced the completion of warrant exercises from its June 2025 public offering, resulting in total aggregate gross proceeds of approximately $128.2 million. The warrants, which had an exercise price of $2.50 per share, expired on September 12, 2026, with the vast majority of exercises occurring between July 1, 2026, and the expiration date.
Addentax Group Corp. entered into a private placement agreement with investor Chan Chun Hong to sell 520,834 shares of common stock at $4.80 per share. The transaction is expected to generate gross proceeds of approximately $2.5 million, which the company intends to use for general corporate purposes and strategic investments.
abrdn Global Infrastructure Income Fund Capital Raise
abrdn Global Infrastructure Income Fund (ASGI) has announced a transferable rights offering for its common shareholders of record as of September 21, 2026. Shareholders will receive one right for every share held, allowing them to subscribe for one new common share for every three rights at a subscription price equal to 92.5% of the average closing market price (or 92.5% of NAV if higher). The fund intends to use the additional capital to invest in global infrastructure assets across power, communications, and transportation sectors.
Rainier Acquisition Corporation announced that holders of units from its $86.25 million initial public offering may elect to separately trade the underlying Class A ordinary shares and warrants starting September 14, 2026. The separated securities will trade on Nasdaq under the symbols RNAQ and RNAQW, while unseparated units continue under RNAQU. The IPO, which included the full exercise of the over-allotment option, was led by Chardan Capital Markets.
Centrus Energy Corp. entered into an underwriting agreement for a public offering of 500,000 shares of Class A common stock, along with pre-funded and common warrants. The proceeds are intended for general corporate purposes, including technology deployment, debt repayment, and potential acquisitions. Guggenheim Securities and Barclays are serving as the book-running managers for the offering.
Greenwave Technology Solutions Capital Raise of $3.75M
Greenwave Technology Solutions closed a private placement of 3,750 shares of Series B Convertible Preferred Stock with five institutional investors. The preferred shares have a stated value of $1,000 per share and are convertible into common stock at an initial conversion price of $5.24 per share. The company filed a Certificate of Designations to authorize the issuance and define the rights of the new preferred securities.
Banzai International entered into a securities purchase agreement for a private placement of convertible promissory notes and warrants with an accredited investor. The deal provides for up to $2.5 million in gross proceeds across three tranches, with $1.5 million funded at the initial closing. The notes carry a 30% original issue discount and are convertible into Class A common stock at a fixed price of $2.75 per share.